During the past decade, CH Chartres conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 7 clinical trials were completed, i.e. on average, 11.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 5 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Chartres" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 11 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 9 trials sponsored, "Nantes University Hospital" with 6 trials sponsored, "Centre Hospitalier Departemental Vendee" with 4 trials sponsored and "Amgen" with 4 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Chartres" #1 collaborator was "University Hospital, Tours" with 4 trials as a collaborator, "Ministry of Health, France" with 3 trials as a collaborator, "University Hospital, Caen" with 3 trials as a collaborator, "University Hospital, Clermont-Ferrand" with 3 trials as a collaborator and "Assistance Publique Hopitaux De Marseille" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "CH Chartres" are "Critical Illness" (5 trials), "Pancreatic Cancer" (5 trials), "Colorectal Cancer" (4 trials), "Lung Cancer" (4 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "CH Chartres" in a lesser frequency.

Most popular intervention types in "CH Chartres" are "Drug" (52 trials), "Other" (26 trials), "Device" (15 trials), "Procedure" (11 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (7 trials), "Placebo" (5 trials), "gemcitabine hydrochloride" (4 trials), "oxaliplatin" (4 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "CH Chartres" are 99 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "CH Chartres". undefined are not yet recruiting, 22 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 54 completed trials in CH Chartres, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in CH Chartres, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 21 trials that are defined as “Not Applicable".

CH Chartres has several departments that took part in Clinical trials: "Hopital Louis Pasteur; Oncologie Hematologie" - 2 trials